牛牛AI助理已提取核心訊息
TC BioPharm (Holdings) PLC, a biopharmaceutical company, has announced a General Meeting (GM) of shareholders to be held on March 14, 2024. The meeting will take place at 2:00 p.m. UK time at the company's registered office in Holytown, Motherwell. The GM will address two ordinary resolutions: the authorization to adjourn the meeting if necessary to solicit further proxies, and the authorization to issue securities in one or more non-public offerings in accordance with Nasdaq Marketplace Rule 5635(d). The latter is a strategic move to raise additional capital up to $4 million, which is crucial for the company's operations and business strategy implementation. The Board of Directors unanimously recommends shareholders vote in favor of the resolutions, emphasizing their alignment with...Show More
TC BioPharm (Holdings) PLC, a biopharmaceutical company, has announced a General Meeting (GM) of shareholders to be held on March 14, 2024. The meeting will take place at 2:00 p.m. UK time at the company's registered office in Holytown, Motherwell. The GM will address two ordinary resolutions: the authorization to adjourn the meeting if necessary to solicit further proxies, and the authorization to issue securities in one or more non-public offerings in accordance with Nasdaq Marketplace Rule 5635(d). The latter is a strategic move to raise additional capital up to $4 million, which is crucial for the company's operations and business strategy implementation. The Board of Directors unanimously recommends shareholders vote in favor of the resolutions, emphasizing their alignment with the company's best interests. Shareholders registered by March 12, 2024, are entitled to vote, and the company has provided detailed instructions for voting, including for holders of American Depositary Shares (ADSs). The GM documentation and voting instruction cards will be distributed accordingly, with a deadline for ADS voting instructions set for March 8, 2024. The company's CEO, Bryan Kobel, has expressed gratitude for the ongoing support and highlighted the importance of the resolutions for the company's future success.
生物製藥公司TC Biopharm（Holdings）PLC宣佈將於2024年3月14日舉行股東大會（GM）。會議將於英國時間下午 2:00 在該公司位於馬瑟韋爾霍利敦的註冊辦事處舉行。總經理將討論兩項普通決議：授權在必要時休會以徵集更多代理人，以及授權根據納斯達克市場規則5635（d）在一次或多次非公開發行中發行證券。後者是一項戰略舉措，旨在籌集高達400萬美元的額外資金，這對於公司的運營和業務戰略的實施至關重要。董事會一致建議股東對這些決議投贊成票，強調這些決議符合公司的最大利益。在2024年3月12日之前註冊的股東有權投票，該公司已提供了詳細的投票說明，包括針對美國存托股份（ADS）持有人的投票說明。通用汽車文件和投票說明卡將相應分發，ADS投票說明的截止日期定爲2024年3月8日。該公司首席執行官布萊恩·科貝爾對持續的支持表示感謝，並強調了這些決議對公司未來成功的重要性。
生物製藥公司TC Biopharm（Holdings）PLC宣佈將於2024年3月14日舉行股東大會（GM）。會議將於英國時間下午 2:00 在該公司位於馬瑟韋爾霍利敦的註冊辦事處舉行。總經理將討論兩項普通決議：授權在必要時休會以徵集更多代理人，以及授權根據納斯達克市場規則5635（d）在一次或多次非公開發行中發行證券。後者是一項戰略舉措，旨在籌集高達400萬美元的額外資金，這對於公司的運營和業務戰略的實施至關重要。董事會一致建議股東對這些決議投贊成票，強調這些決議符合公司的最大利益。在2024年3月12日之前註冊的股東有權投票，該公司已提供了詳細的投票說明，包括針對美國存托股份（ADS）持有人的投票說明。通用汽車文件和投票說明卡將相應分發，ADS投票說明的截止日期定爲2024年3月8日。該公司首席執行官布萊恩·科貝爾對持續的支持表示感謝，並強調了這些決議對公司未來成功的重要性。
有用
沒用